| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | $1.50B | $1.41B | $1.32B | $1.15B |
| R&D | – | – | – | – | – |
| SG&A | $83.01M | $83.59M | $74.61M | $68.06M | $56.44M |
| Operating Income | – | – | – | – | – |
| Interest Expense | $185.20M | $165.35M | $140.20M | $134.87M | $114.89M |
| Tax Expense | – | – | – | – | – |
| Net Income | $513.39M | $468.14M | $432.14M | $310.02M | $210.56M |
| EPS (basic) | 1.1800 | 1.0800 | 1.0100 | 0.7200 | 0.4200 |
| EPS (diluted) | 1.1800 | 1.0800 | 1.0100 | 0.7100 | 0.4100 |
| Shares (diluted) | $370.91M | $367.99M | $362.48M | $349.79M | $325.52M |